Philips wins Dutch court battle over recall: stock pre-market at EUR 21.61
Published on 10/12/2026 at 08:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- A Dutch court rejected shareholder demands for an investigation into Philips’ handling of its sleep apnea device recall.
- Philips stock was at EUR 21.61 pre-market at Lang & Schwarz on October 12, 2026, at 8:43 a.m. CEST.
- The ruling addressed whether an investigation should be ordered, not investor compensation claims.
A Dutch court rejected shareholder demands for an investigation into Koninklijke Philips N.V.’s handling of its 2021 sleep apnea device recall, according to a report published October 10, 2026. Philips stock was at EUR 21.61 at Lang & Schwarz on October 12, 2026, at 8:43 a.m. CEST.
Court ruling on recall investigation
The Enterprise Chamber of the Amsterdam Court of Appeal found insufficient grounds to question Philips’ policies and management practices or to order an inquiry. The court said it found no evidence that Philips’ executive and supervisory boards received reliable information about health risks from the foam used in the devices too late. The ruling did not determine whether errors were made at Respironics or whether investors were entitled to compensation. Yahoo Finance reported the decision.
What matters today
The court decision followed shareholder claims linked to Philips’ recall of around 15 million sleep apnea and respiratory devices in 2021. Philips agreed in 2024 to pay USD 1.10 billion to settle personal-injury claims related to the devices filed in the United States. The company’s investor-relations page lists October 8, 2026, as the date of its latest press release.
The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Philips stock.
Market context: Market report AEX.
